| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. (WVE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. WVE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.98M | $162.39M | - | |
| Dir | 5.73M | $34.49M | - | |
| Other | 408.2K | $2.46M | - | |
| Dir | 283.2K | $1.70M | - | |
| CEO | 275.5K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | Francis Chris70 | See Remarks | Sale+OE | 48,992 | $46.75 | $2,290,376.00 | -52.6% | |
| May 30, 2018 | Bolno Paul64 | President And CEO | Sale+OE | 31,711 | $45.00 | $1,426,995.00 | -3.7% | |
| May 2, 2018 | Bolno Paul64 | President And CEO | Sale+OE | 18,289 | $45.00 | $823,005.00 | -6.2% | |
| Feb 20, 2018 | Francis Chris70 | See Remarks | Sale+OE | 21,639 | $55.40 | $1,198,760.20 | -24.6% | |
| Feb 16, 2018 | Bolno Paul64 | President And CEO | Sell | 2,714 | $51.50 | $139,783.14 | -0.5% | |
| Feb 16, 2018 | Panzara Michael A. | Franchise Lead, Neurology | Sell | 511 | $52.10 | $26,623.10 | -1.3% | |
| Feb 16, 2018 | Regnante Keith | Chief Financial Officer | Sell | 316 | $51.85 | $16,384.60 | -1.8% | |
| Feb 15, 2018 | Vargeese Chandra | See Remarks | Sale+OE | 2,000 | $50.00 | $100,000.00 | -6.8% | |
| Feb 15, 2018 | Panzara Michael A. | Franchise Lead, Neurology | Sale+OE | 18,750 | $50.00 | $937,500.00 | -32.1% | |
| Jan 23, 2018 | Vargeese Chandra | See Remarks | Sale+OE | 2,000 | $40.00 | $80,000.00 | -16.9% |